Crinetics Pharmaceuticals CRNX Enterprise value

Enterprise value at other companies

Neurocrine BiosciencesNBIX

$13.41B+18.5%

Corcept TherapeuticsCORT

$9.23B+14.7%

BridgeBio PharmaBBIO

$16.77B+178%

MBX Biosciences, Inc.MBX

$1.37B+533%

XER

Xeris Biopharma Holdings, Inc.XERS

$1.54B+62.6%

Viking TherapeuticsVKTX

$3.81B-14.5%

FAQ

What is Crinetics Pharmaceuticals's enterprise value?

Crinetics Pharmaceuticals (CRNX) reported enterprise value of $3.74B in Q1 2026.

How has Crinetics Pharmaceuticals's enterprise value changed year-over-year?

Crinetics Pharmaceuticals's enterprise value increased by 21.5% year-over-year, from $3.08B to $3.74B.

What is the long-term trend for Crinetics Pharmaceuticals's enterprise value?

Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's enterprise value has grown at a 49.6% compound annual growth rate (CAGR), from $581.99M to $4.36B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.